LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.5300
0.00 (0.00%)
At close: Oct 27, 2025
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 96.26 million as of October 27, 2025. Its market cap has decreased by -69.62% in one year.
Market Cap
96.26M
Enterprise Value
64.45M
Revenue
1.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 96.26M, an increase of 81.68%. That is a compound annual growth rate of 37.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 95.35M | -34.96% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.70B |
| Pro Medicus | 29.45B |
| Cochlear | 18.98B |
| Sonic Healthcare | 10.75B |
| Ramsay Health Care | 7.34B |
| Telix Pharmaceuticals | 5.59B |
| Ansell | 4.84B |
| Mesoblast | 3.29B |